Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

A new mobile prostate cancer screening unit has just been launched by Mount Sinai Health in New York City.

Mobile prostate cancer screening unit hits the streets of NYC

The Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit was developed with the intention of increasing access to screening and supporting prostate health in the Black community.

Thumbnail

Individualized communications increase colorectal cancer screening completion

Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.

mammography mammogram breast cancer

New data on false positive rates for DBT and DM screenings

Digital breast tomosynthesis exams produce fewer false positive results than standard two-dimensional mammography, though not substantially, experts shared recently in JAMA Open Network.

Thumbnail

Radiologists should be mindful of extracolonic findings on CTC scans of cancer patients

Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging

Thumbnail

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

The research focused on a radiopharmaceutical that contains the isotope zirconium 89, which has a significantly longer half-life compared to gallium-68-labelled PSMA ligands.

colon colorectal cancer CTC

CT-based radiomics nomogram accurately predicts colorectal cancer prognosis

The study's findings could be used to help clinicians guide treatment decisions for CRC patients, experts suggested in Academic Radiology.

FDA approves new radioligand therapy for PSMA positive metastatic prostate cancer

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression. 

Thumbnail

Research advocates for the return of positive oral contrast in abdominopelvic CT exams

Use of such agents has diminished in recent years, but there is still a great need for oral contrast among oncology patients, experts report in AJR. 

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.